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QUESTIONS
1. How do transcription factors regulate cancer initiation and growth?
2. Why did the investigators carry out their study?
3. What were the results?
4. What were their conclusions?
Skin cancer affects more Americans than all other cancers 
combined, with well over 1 million Americans diagnosed with 
melanoma and nonmelanoma skin cancers each year (Federman, 
2009). Therefore, a better understanding of the mechanisms 
involved in skin cancer development is of great importance. 
Cancer development is, in part, under genetic control, and tran-
scription factors (TFs), which are sequence-specific DNA-binding 
proteins that control transcriptional activation or repression and 
thus control cell growth, are important in this process. Although 
most TFs perform this function alone, these molecules often recruit 
partners to form multiunit complexes (Brach et al., 1996), which can 
alter the TF-binding specificity and thus alter the response.
Activator protein 1 (AP-1) is a heterodimeric TF that consists of 
members of the Jun and Fos gene families, which include c-Jun, JunB, and others (Rorke et al., 2010). AP-1 poten-
tially promotes skin cancer development via its control of keratinocyte survival and differentiation. Within the 
AP-1 complex, however, individual gene families, such as c-Jun and JunB, may function differently via different 
interactions with partner molecules, such as the oncogene RAS. Understanding how each of these components 
and complexes functions is critical to developing targeted therapies for skin cancers.
In a study reported in this issue, Jin et al. explored the roles of c-Jun and JunB in promoting skin tumor develop-
ment. In human squamous cell carcinomas (SCCs), c-Jun was activated, and coexpression of c-Jun with Ras trans-
formed epidermal cells in a skin grafting model. Conversely, JunB was not induced in most SCC cells, and JunB 
inhibited tumorigenesis driven by Ras. Through the following questions, we examine this paper in greater detail. 
For brief answers, please refer to the supplementary information online <http://www.nature.com/jid/journal/v131/
n5/suppinfo/jid201179s1.html>.
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